Cyberknife Market Report 2026

Cyberknife Market Overview

• Cyberknife market size has reached to $0.72 billion in 2025 • Expected to grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 16.6% • Growth Driver: Rising Demand For Minimally Invasive Solutions Driving Growth In The Cyberknife Market • Market Trend: Innovative Solutions In The CyberKnife Market Enhance Treatment Precision And Patient Outcomes • North America was the largest region in 2025.

What Is Covered Under Cyberknife Market?

The CyberKnife System is a non-invasive treatment for malignant and non-cancerous tumors and other disorders where radiation therapy is recommended. This allows for smaller treatment margins around the tumor, minimizing the amount of healthy tissue exposed to a high radiation dose. The main types of cyberknife are linear accelerator-based and standalone cyberknife. Linear accelerator-based cyberknife refers to a cyberknife system that uses a linear accelerator (linac) installed directly on a robot to deliver the high-energy photons or X-rays required in radiation therapy. A linear accelerator-based cyberknife device is used to deliver high-energy X-rays or photons used in radiation therapy. The cyberknife systems are used for treating tumors, cancer, vascular malformation, and others in hospitals, clinics, ambulatory surgical centers, radiotherapy centers, and others.

What Is The Cyberknife Market Growth Forecast?

The cyberknife market size is expected to see rapid growth in the next few years. It will grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing investments in precision oncology, rising demand for outpatient cancer treatments, expansion of advanced cancer care facilities, growing integration of ai in radiation planning, increasing focus on patient-specific therapy optimization. Major trends in the forecast period include increasing adoption of robotic radiosurgery systems, rising use of image-guided radiation therapy, growing demand for non-invasive tumor treatments, expansion of precision radiation platforms, enhanced focus on treatment accuracy and safety.

Global Cyberknife Market Segmentation

1) By System Configuration: Fixed CyberKnife Systems, Robotic-Arm CyberKnife Systems, Upgraded And Refurbished CyberKnife Systems 2) By Application: Cancer Treatment, Benign Tumor Treatment, Vascular Malformations, Functional And Other Neurological Disorders 3) By Anatomical Site: Brain And Central Nervous System, Spine And Spinal Cord, Lung And Thoracic Region, Prostate And Pelvic Region, Liver And Abdominal Region, Other Anatomical Sites 4) By End User: Hospitals, Dedicated Radiotherapy Centers, Cancer Specialty Centers, Academic And Research Institutes Subsegments: 1) By Fixed CyberKnife Systems: Single-Room Fixed CyberKnife Systems, Shielded Bunker-Based Fixed Systems, Integrated Imaging Fixed CyberKnife Systems, High-Throughput Fixed CyberKnife Systems 2) By Robotic-Arm CyberKnife Systems: Multi-Axis Robotic-Arm CyberKnife Systems, Real-Time Motion-Tracking Robotic Systems, Image-Guided Robotic-Arm CyberKnife Systems, Adaptive And AI-Enabled Robotic CyberKnife Systems 3) By Upgraded And Refurbished CyberKnife Systems: Software-Upgraded CyberKnife Systems, Hardware-Refurbished CyberKnife Systems, Imaging And Tracking Module Upgrades, Workflow And Treatment Planning Upgrades

What Is The Driver Of The Cyberknife Market?

Growing preference for non-invasive or minimally invasive procedures is expected to propel the growth of the cyberknife market going forward. Minimally invasive procedures refer to medical interventions that are performed with the least possible disruption to the body's normal structures. CyberKnife, a robotic radiosurgery system, offers several benefits in minimally invasive procedures such as precise targeting of tumors, adaptability to moving targets, reduced number of treatment sessions, enhanced comfort for patients, and others. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the growing preference for non-invasive or minimally invasive procedures is driving the growth of the cyberknife industry.

Key Players In The Global Cyberknife Market

Major companies operating in the cyberknife market are Accuray Incorporated, Elekta AB, Siemens Healthineers AG, Canon Medical Systems Corporation, Hitachi Ltd., Mitsubishi Electric Corporation, Ion Beam Applications S.A., Mevion Medical Systems Inc., Zap Surgical Systems Inc., ViewRay Inc., RefleXion Medical Inc., Shinva Medical Instrument Co. Ltd., Best Theratronics Ltd., Advanced Oncotherapy PLC, Sumitomo Heavy Industries Ltd., ProTom International Inc., GE HealthCare Technologies Inc., Nordion Inc., Theragenics Corporation, IsoRay Medical Inc.

Global Cyberknife Market Trends and Insights

Major players operating in the cyberknife market are focusing on developing innovative solutions, such as medical training programs, to enhance treatment precision, improve patient outcomes, and expand the range of treatable conditions while minimizing side effects associated with traditional radiation therapies. Medical training programs refer to structured educational initiatives designed to enhance the skills and knowledge of healthcare professionals, focusing on specific medical technologies, treatments, and best practices to improve patient care outcomes. For instance, in September 2024, Accuray Incorporated, a US-based radiation therapy systems manufacturer company, opened the CyberKnife S7 System medical professional training at its education center. This facility serves as a comprehensive education center aimed at enhancing the skills of medical professionals involved in radiosurgery and radiotherapy, offering tailored training programs and hands-on experience with the CyberKnife and Radixact systems.

What Are Latest Mergers And Acquisitions In The Cyberknife Market?

In June 2024, Accuray Incorporated, a US-based radiation oncology company, partnered with TrueNorth Medical Physics to expand access to specialized radiation oncology support services for improved cancer care. This partnership aims to enhance treatment quality, strengthen clinical capabilities, and support more centers in delivering advanced, patient-focused cancer treatments. TrueNorth Medical Physics LLC is a US-based company that provides services for the CyberKnife system, including physics, dosimetry, and commissioning support.

Regional Outlook

North America was the largest region in the cyberknife market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cyberknife Market?

The cyberknife market consists of sales of robotic linac, robotic manipulator, image guidance system, image tracking system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.